PFBT
RCUS icon

Parkside Financial Bank & Trust’s Arcus Biosciences RCUS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62K Hold
85
– – ﹤0.01% 2088
2026
Q1 		$1.84K Hold
85
– – ﹤0.01% 2147
2025
Q4 		$2.03K Hold
85
– – ﹤0.01% 2088
2025
Q3 		$1.16K Hold
85
– – ﹤0.01% 2223
2025
Q2 		$693 Buy
+85
New +$726 ﹤0.01% 2387
2024
Q4 		– Sell
-15
Closed -$230 – 2180
2024
Q3 		$230 Buy
15
+4
+36% +$63 ﹤0.01% 1988
2024
Q2 		$168 Sell
11
-2
-15% -$32 ﹤0.01% 1970
2024
Q1 		$246 Hold
13
– – ﹤0.01% 1895
2023
Q4 		$249 Sell
13
-139
-91% -$2.22K ﹤0.01% 1901
2023
Q3 		$2.73K Hold
152
– – ﹤0.01% 1563
2023
Q2 		$3.09K Hold
152
– – ﹤0.01% 1546
2023
Q1 		$2.77K Sell
152
-11
-7% -$210 ﹤0.01% 1598
2022
Q4 		$3.37K Hold
163
– – ﹤0.01% 1487
2022
Q3 		$4K Buy
163
+77
+90% +$2.04K ﹤0.01% 1330
2022
Q2 		$2K Buy
+86
New +$2.11K ﹤0.01% 1618

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Parkside Financial Bank & Trust's RCUS Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 85 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

Parkside Financial Bank & Trust first reported a position in RCUS in Q2 2022 and has held it in 15 quarters since. The position peaked at $4K in Q3 2022. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Parkside Financial Bank & Trust held 85 shares of Arcus Biosciences worth $2.62K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2088 holding.
  • Parkside Financial Bank & Trust first reported a position in Arcus Biosciences in Q2 2022 and has held it in 15 quarters since.
  • Parkside Financial Bank & Trust's Arcus Biosciences position peaked at $4K in Q3 2022.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.